Cellcraft is a Cambridge-based, B2B, AI-native start-up building the AI & Automation systems to unlock and power bio-manufacturing, which includes biopharma (including vaccines), fermentation, cultivated meat, cell and gene therapies, etc.

Our first product, Cellcraft IQ, is the world's 1st AI Plug-and-Play Operating System for Bio-Manufacturing. This AI-native bioprocess automation and optimisation software turns any bioreactor into an intelligent, self-optimising systems.

Cellcraft IQ can reduce inefficiency, costs and failure rates, whilst address key industry bottlenecks: high costs and variability, low efficiency, and the lack of real-time insight and adaptive optimisation in bio-manufacturing.

We have filed a patent for our platform, which is built around an Ensemble AI architecture combining machine learning, physics-constrained modelling, and adaptive control.